AI Image
Trump's final GLOBE rule will save Medicare much less money
STAT • • world
Key Points:
- The Trump administration finalized a rule called the Global Benchmark for Efficient Drug Pricing (GLOBE) to lower Medicare drug prices for drugs administered in doctor offices, targeting only four companies.
- GLOBE is one of two mandatory pilot programs under Trump's plan to align Medicare drug prices with those charged in other wealthy countries, known as most-favored nation (MFN) pricing.
- The second pilot program, GUARD, remains in the proposed stage and has not yet been finalized.
- Companies participating in separate voluntary MFN pricing deals for Medicaid drugs are exempt from the GLOBE pilot program.
